Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/53080
Share/Impact:
Título : Pathogenic lysosomal depletion in Parkinson´s disease
Autor : Dehay, B., Bové, Jordi, Rodríguez-Muela, N., Perier, C., Recasens, A., Boya Tremoleda, Patricia, Vila, M.
Fecha de publicación : 15-Sep-2010
Editor: Society for Neuroscience
Citación : Journal of Neuroscience, 30 (37) : 12535-1254 (2010)
Resumen: Mounting evidence suggests a role for autophagy dysregulation in Parkinson's disease (PD). The bulk degradation of cytoplasmic proteins (including α-synuclein) and organelles (such as mitochondria) is mediated by macroautophagy, which involves the sequestration of cytosolic components into autophagosomes (AP) and its delivery to lysosomes. Accumulation of AP occurs in postmortem brain samples from PD patients, which has been widely attributed to an induction of autophagy. However, the cause and pathogenic significance of these changes remain unknown. Here we found in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of PD that AP accumulation and dopaminergic cell death are preceded by a marked decrease in the amount of lysosomes within dopaminergic neurons. Lysosomal depletion was secondary to the abnormal permeabilization of lysosomal membranes induced by increased mitochondrial-derived reactive oxygen species. Lysosomal permeabilization resulted in a defective clearance and subsequent accumulation of undegraded AP and contributed directly to neurodegeneration by the ectopic release of lysosomal proteases into the cytosol. Lysosomal breakdown and AP accumulation also occurred in PD brain samples, where Lewy bodies were strongly immunoreactive for AP markers. Induction of lysosomal biogenesis by genetic or pharmacological activation of lysosomal transcription factor EB restored lysosomal levels, increased AP clearance and attenuated 1-methyl-4-phenylpyridinium-induced cell death. Similarly, the autophagy-enhancer compound rapamycin attenuated PD-related dopaminergic neurodegeneration, both in vitro and in vivo, by restoring lysosomal levels. Our results indicate that AP accumulation in PD results from defective lysosomal-mediated AP clearance secondary to lysosomal depletion. Restoration of lysosomal levels and function may thus represent a novel neuroprotective strategy in PD
Descripción : 10 páginas, 7 figuras -- PAGS nros. 12535-12544
Versión del editor: http://dx.doi.org/10.1523/JNEUROSCI.1920-10.2010
URI : http://hdl.handle.net/10261/53080
ISSN: 0270-6474
DOI: 10.1523/JNEUROSCI.1920-10.2010
Appears in Collections:(CIB) Artículos

Files in This Item:
File Description SizeFormat 
restringido.pdf21,67 kBAdobe PDFView/Open
Show full item record
 
CSIC SFX LinksSFX Query
Related articles:


Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.